Fig. 6.

OA supplementation of differentiating CPCs: (A) Cell morphology of CPCs differentiated using the TGF-β1 protocol, followed by 1 week of OA 300 μM supplementation, under light microscope (scale bars: 100 μM). (B) Effect of OA treatment post-differentiation on CPCs, compared to non-treated differentiated CPCs and CNTRL undifferentiated P4 CPCs. (n = 4, *p < .02, $p < .01 compared to CNTRL, error bars: standard error). (C) Immunocytochemistry on control undifferentiated samples (top two rows) and differentiated samples with OA addition (DIFF+OA; bottom two rows). (MYH7 and TNNT2 shown in green, co-stained with DAPI in blue, scale bars: 50 μm). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)